OP-DAPA 10
OP-DAPA 10 is a pharmaceutical product/formulation containing Dapagliflozin 10 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.
OPTAGLIM MV2
OPTAGLIM MV2 is a pharmaceutical product/formulation containing Glimepiride 2 mg + Metformin 500 mg + Voglibose 0.2 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.
OPTAGLIM MV1
OPTAGLIM MV1 is a pharmaceutical product/formulation containing Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.2 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.
OPTAGLIM MP2
OPTAGLIM MP1 is a pharmaceutical product/formulation containing Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.
OPTAGLIM MP1
OPTAGLIM MP1 is a pharmaceutical product/formulation containing Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.
OPTAGLIM M2
OPTAGLIM M2 is a pharmaceutical product/formulation containing Glimepiride 2 mg + Metformin 500 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.
OPTAGLIM M1
OPTAGLIM M1 is a pharmaceutical product/formulation containing Glimepiride 1 mg + Metformin 500 mg. It is part of the Optalogic Pharma portfolio of diabetes-focused products.